Tafazzin Polyclonal Antibody, Cy7 Conjugated, Rabbit

Artikelnummer: BSS-BS-15504R-CY7
Artikelname: Tafazzin Polyclonal Antibody, Cy7 Conjugated, Rabbit
Artikelnummer: BSS-BS-15504R-CY7
Hersteller Artikelnummer: bs-15504R-Cy7
Alternativnummer: BSS-BS-15504R-CY7-100
Hersteller: Bioss
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IF, WB
Konjugation: Cy7
Alternative Synonym: Barth syndrome, Cardiomyopathy dilated 3A X linked, EFE2, Endocardial fibroelastosis 2, Protein G4.5, Tafazzin, TAZ, TAZ protein, TAZ protein, TAZ_HUMAN.
This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.
Klonalität: Polyclonal
Konzentration: 1ug/ul
NCBI: 6901
Puffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Quelle: KLH conjugated synthetic peptide derived from human Tafazzin
Target-Kategorie: Tafazzin
Application Verdünnung: WB(1:300-5000), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)